Methylprednisolone acetate–Eudragit® RS100 electrospuns: Preparation and physicochemical characterization
Source abstract
Abstract
The aim of the present study was to formulate methylprednisolone acetate -Eudragit(®) RS100 nanofibers and nanobeads by the electrospinning method. The physicochemical characteristics of the prepared electrospuns were assessed as well. The particle size and morphology were evaluated using scanning electron microscopy. The crystallinity of the drug in the nanofibers and nanobeads obtained was also studied by X-ray crystallography and differential scanning calorimetry (DSC) thermograms. In addition, FT-IR spectroscopy was applied to investigate any possible chemical interaction between the drug and carrier during the preparation process. The drug release kinetics were considered, to predict the release mechanism. Increasing the concentration of the injected solution resulted in the production of more nanofibers and less nanobeads, with the particle size ranging from 100 to 500 nm. The drug crystallinity was decreased during the electrospinning process; however, no interaction between drug and polymer was observed. The electrospuns showed faster drug release pattern compared to the pure drug. The release data were best fitted to the Weibull model, in which the corresponding shape factor values of the model were less than 0.75 indicating the diffusion mechanism of drug release. In conclusion, electrospinning could be considered as a simple and cost effective method for fabricating the drug: polymer nanofibers and nanobeads.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
Student Research Committee and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
Novel Drug Delivery Research Center, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
References (51)
Show source-provided references
1. 10.1016/j.colsurfb.2010.11.01410.1016/j.colsurfb.2010.11.014 ↗
2. 10.1089/jop.2007.003910.1089/jop.2007.0039 ↗
3. 10.1080/1061186070145312510.1080/10611860701453125 ↗
4. 10.1080/1061186070145312510.1080/10611860701453125 ↗
5. Akhgari A · Adv Pharm Bull · 2013 · 3 · 85
6. 10.18433/J3D59T10.18433/J3D59T ↗
7. 10.18433/J3D59T10.18433/J3D59T ↗
8. 10.1016/j.biotechadv.2010.01.00410.1016/j.biotechadv.2010.01.004 ↗
9. Canbolat MF · Colloids Surf B Biointerfaces · 2013 · 115 · 1510.1016/j.colsurfb.2013.11.021 ↗
10. Chaturvedi TP · J Clin Diagn Res · 2013 · 7 · 2339
11. 10.1016/j.ijhydene.2012.09.17010.1016/j.ijhydene.2012.09.170 ↗
12. Chowdhury M · Int J Basic Appl Sci · 2010 · 10 · 70
13. 10.1016/S0928-0987(01)00095-110.1016/S0928-0987(01)00095-1 ↗
14. 10.2337/diab.37.2.24610.2337/diab.37.2.246 ↗
15. Douglas S · Crit Rev Ther Drug Carrier Syst · 1986 · 3 · 233
16. Doustgani A · Int J Nanosci Nanotechnol · 2011 · 7 · 127
17. 10.1016/S0939-6411(03)00005-510.1016/S0939-6411(03)00005-5 ↗
18. Hwang J · . Int J Nanomed · 2008 · 3 · 359
19. 10.1002/jps.2375910.1002/jps.23759 ↗
20. 10.1016/j.colsurfb.2010.07.04710.1016/j.colsurfb.2010.07.047 ↗
21. 10.1016/j.jconrel.2004.04.00910.1016/j.jconrel.2004.04.009 ↗
22. 10.1016/j.ijpharm.2006.01.00810.1016/j.ijpharm.2006.01.008 ↗
23. Krishna Sailaja A · Int J Pharm Pharm Sci · 2011 · 3
24. 10.1016/j.biomaterials.2006.08.04910.1016/j.biomaterials.2006.08.049 ↗
25. Loveymi BD · Adv Pharm Bull · 2012 · 2 · 43
26. 10.1016/S0168-3659(03)00097-X10.1016/S0168-3659(03)00097-X ↗
27. 10.1179/174328008X35354710.1179/174328008X353547 ↗
28. 10.1163/092050610X54048610.1163/092050610X540486 ↗
29. 10.1016/j.colsurfb.2010.05.02710.1016/j.colsurfb.2010.05.027 ↗
30. 10.1021/mp400231p10.1021/mp400231p ↗
31. 10.1089/ten.2006.12.119710.1089/ten.2006.12.1197 ↗
32. 10.1080/10717540130000274810.1080/107175401300002748 ↗
33. 10.1016/S0928-0987(02)00057-X10.1016/S0928-0987(02)00057-X ↗
34. 10.1080/02652040028833710.1080/026520400288337 ↗
35. Pires LR · J Tissue Eng Regen Med · 2013
36. 10.1016/0002-9343(92)90294-L10.1016/0002-9343(92)90294-L ↗
37. 10.1166/jnn.2009.115510.1166/jnn.2009.1155 ↗
38. 10.1345/aph.1005410.1345/aph.10054 ↗
39. 10.1016/j.biomaterials.2007.09.01210.1016/j.biomaterials.2007.09.012 ↗
40. 10.1166/jnn.2013.715710.1166/jnn.2013.7157 ↗
41. Snopczynski T · Rocz Panstw Zakl Hig · 2009 · 60 · 101
42. 10.1039/c3nr02421k10.1039/c3nr02421k ↗
43. 10.1002/app.2148110.1002/app.21481 ↗
44. 10.1016/S0378-5173(99)00070-810.1016/S0378-5173(99)00070-8 ↗
45. 10.1039/b809074m10.1039/b809074m ↗
46. 10.1016/j.ijpharm.2013.08.08510.1016/j.ijpharm.2013.08.085 ↗
47. 10.1002/jps.260058102110.1002/jps.2600581021 ↗
48. 10.1021/nl020216u10.1021/nl020216u ↗
49. 10.4236/health.2009.1201210.4236/health.2009.12012 ↗
50. 10.1016/j.polymer.2006.04.05010.1016/j.polymer.2006.04.050 ↗
51. 10.1016/j.ejpb.2012.04.00110.1016/j.ejpb.2012.04.001 ↗